Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "physical attenuation of ionizing radiation via high atomic number compounds" refers to the use of materials with a *high atomic number (Z)* and typically high density to absorb or reduce (attenuate) the intensity of ionizing radiation, including gamma rays, X-rays, and some particle radiation[2][4][10]. The efficiency of a material for radiation shielding increases with its atomic number and density, as these properties facilitate absorption and scattering of radiation through physical interactions (photoelectric effect, Compton scattering, pair production for photons, and nuclear interactions for neutrons)[2][4][7]. Common high-Z shielding materials include **lead (Z=82), tungsten (Z=74), bismuth (Z=83)**, and sometimes specialized transition metal compounds or polymers embedded with high-Z elements[2][4][10]. Such materials are used in medical imaging, nuclear energy, and research settings to protect personnel and sensitive equipment from harmful radiation[2][4][8]. This is not a discrete drug target or biomolecule but a category of *functional materials* engineered for physical protection against ionizing radiation. **Note:** Since this entry does not describe a biological molecular target, it should not be considered as such for therapeutic drug discovery or molecular mechanism studies. The concept is widely applied in *materials science, health physics, and radiation safety engineering* but does not map to canonical target nomenclature used in pharmacology, biochemistry, or molecular biology[2][4][10].
Physical absorption and scattering of ionizing radiation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical attenuation of ionizing radiation via high atomic number compounds.